Library — CHDR

Search

Filter

A Placebo-Controlled Study to Assess the Sensitivity of Finger Tapping to Medication Effects in Parkinson's Disease.

Thijssen E, Makai-Bölöni S, van Brummelen E, den Heijer J, Yavuz Y, Doll RJ, Groeneveld GJ

Movement disorders clinical practice, 2022 Nov; 9(8):1074-1084

View publication
Intravenous immunoglobulin (IVIg) therapy in hospitalised adult COVID-19 patients: A systematic review and meta-analysis.

Marcec R, Dodig VM, Radanovic I, Likic R

Reviews in medical virology, 2022 Nov; 32(6):e2397

View publication
Effects of Mexiletine and Lacosamide on Nerve Excitability in Healthy Subjects: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study.

Ruijs TQ, Koopmans IW, de Kam ML, van Esdonk MJ, Koltzenburg M, Groeneveld GJ, Heuberger JAAC

Clinical pharmacology and therapeutics, 2022 Nov; 112(5):1008-1019

View publication
Safety and Immunogenicity of Intradermal Fractional Dose Administration of the mRNA-1273 Vaccine: A Proof-of-Concept Study.

Roozen GVT, Prins MLM, van Binnendijk R, den Hartog G, Kuiper VP, Prins C, Janse JJ, Kruithof AC, Feltkamp MCW, Kuijer M, Rosendaal FR, Roestenberg M, Visser LG, Roukens AHE

Annals of internal medicine, 2022 Oct

View publication
A systematic review on disease-drug-drug interactions with immunomodulating drugs: A critical appraisal of risk assessment and drug labelling.

de Jong LM, Klomp SD, Treijtel N, Rissmann R, Swen JJ, Manson ML

British journal of clinical pharmacology, 2022 Oct; 88(10):4387-4402

View publication
White Blood Cell and Platelet Counts Are Not Suitable as Biomarkers in the Differential Diagnostics of Dementia.

Schröder S, Heck J, Groh A, Frieling H, Bleich S, Kahl KG, Bosch JJ, Krichevsky B, Schulze-Westhoff M

Brain sciences, 2022 Oct

View publication
In Reply: Neoadjuvant TKI Study in Early- and Intermediate Stage Hepatocellular Carcinoma.

Osanto S, Woei-A-Jin FJSH, Coenraad MJ, Weijl NI, Burgmans MC, Burggraaf J

The oncologist, 2022 Oct

View publication
A system pharmacology Boolean network model for the TLR4-mediated inflammatory response in early sepsis.

Liu F, Aulin LBS, Kossen SSA, Cathalina J, Bremmer M, Foks AC, van der Graaf PH, Moerland M, van Hasselt JGC

Journal of pharmacokinetics and pharmacodynamics, 2022 Oct

View publication
Viral clearance, pharmacokinetics and tolerability of ensovibep in patients with mild to moderate COVID-19: A phase 2a, open-label, single-dose escalation study.

Prins MLM, van der Plas JL, Vissers MFJM, Berends CL, Tresch G, Soergel M, Fernández E, van den Berge N, Duijsings D, Zitt C, Stavropoulou V, Zimmermann M, Drake RF, Burggraaf J, Groeneveld GH, Kamerling IMC

British journal of clinical pharmacology, 2022 Oct

View publication

«
1
2
3
4
5
6
7
8
...
95
96
»